IMRIS Inc. (IMRSQ) Research

Based in Winnipeg, Canada, and established in 2005, IMRIS Inc. is a global leader in developing, producing, and distributing advanced image-guided therapy solutions. The company's flagship offering is the VISIUS Surgical Theatre, a sophisticated operating room environment. This unique system empowers medical professionals with real-time, intraoperative visual data, thereby aiding critical decision-making and significantly boosting the precision of patient treatments. The VISIUS Surgical Theatre integrates advanced imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and fluoroscopy directly into multi-purpose surgical suites, bringing state-of-the-art diagnostic capabilities right into the operating room for diverse medical procedures. IMRIS primarily sells these integrated theatres to hospitals that provide clinical care in neurosurgical, spinal, cerebrovascular, and cardiovascular specialties. Complementing its core systems, the company also offers comprehensive service plans, extended maintenance agreements, and a variety of essential accessories and disposables.

Market snapshot

Symbol
IMRSQ
Price
$0.00
Day change
0.00%
Market cap
$626.0
P/E ratio
-0.00x
52-week range
0.000001-0.00001
Sector
Healthcare
Industry
Medical - Specialties

Peer companies

  • Ampio Pharmaceuticals, Inc. (AMPE)
  • Bloomios, Inc. (BLMS)
  • Better Therapeutics, Inc. (BTTX)
  • CEN Biotech, Inc. (CENBF)
  • Dermisonics, Inc. (DMSI)
  • SpectraScience, Inc. (SCIE)
  • Statera Biopharma, Inc. (STAB)
  • Strategic Global Investments, Inc. (STBV)

Open IMRIS Inc. (IMRSQ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.